Study examines prevalence of rheumatic heart disease in developing country

Thomas Pilgrim, M.D., of Bern University Hospital, Bern, Switzerland, and colleagues conducted a study to determine the prevalence and incidence of clinically silent and manifest rheumatic heart disease in Eastern Nepal. The study was published online by JAMA Cardiology.

Three in 4 children grow up in parts of the world where (RHD) is endemic. Nearly eradicated in high-income countries, RHD ranks among the important noncommunicable diseases in low- and middle income countries. It is a sentinel of social inequality and a physical manifestation of poverty and continues to be a substantial health care challenge in less privileged regions of the world. This study included 5,178 children, 5 to 15 years of age, from Eastern Nepal. A focused medical history was followed by a brief physical examination. Cardiac auscultation (listening to the heart with a stethoscope) and transthoracic echocardiography were performed by 2 independent physicians.

The prevalence of borderline or definite rheumatic heart disease was 10.2 per 1,000 children and increased with advancing age from 5.5 per 1,000 children 5 years of age to 16.0 in children 15 years of age, whereas the average incidence remained stable at 1.1 per 1,000 children per year. Children with rheumatic heart disease were older than children without rheumatic and more often female. Silent disease (n = 44) was 5 times more common than manifest disease (n = 9).

"Early detection of silent disease may help prevent progression to severe valvular damage," the authors write.


Explore further

Test reveals widespread heart disease among children  

More information: JAMA Cardiology. Published online March 2, 2016; DOI: 10.1001/jamacardio.2015.0292
Citation: Study examines prevalence of rheumatic heart disease in developing country (2016, March 2) retrieved 22 October 2020 from https://medicalxpress.com/news/2016-03-prevalence-rheumatic-heart-disease-country.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments